Factors | Univariate logistic regression | Multivariate logistic regression | ||
OR (95% CI) | P | OR (95% CI) | P | |
Gender | 1.518 (1.019 - 2.261) | 0.06 |
|
|
Age | 1.278 (0.745 - 2.191) | 0.27 |
|
|
Tumor size | 0.803 (0.572 - 1.126) | 0.09 |
|
|
Extragrandular invasion | 1.601 (1.037 - 2.473) | 0.02* | 1.448 (0.801 - 2.619) | 0.17 |
Multifocality | 0.623 (0.424 - 0.914) | 0.02* | 0.913 (0.377 - 2.212) | 0.14 |
Microcarcinoma | 0.999 (0.651 - 1.533) | 0.76 |
|
|
Bilateral lesions | 1.664 (1.114 - 2.485) | 0.03* | 1.636 (0.648 - 4.126) | 0.57 |
HT | 1.286 (0.172 - 0.475) | <0.0001* | 0.488 (0.255 - 0.934) | 0.04* |
BRAFV600E mutation | 0.727 (0.496 - 0.1064) | 0.1 |
|
|
Central lymph node metastasis | 0.939 (0.900 - 0.980) | 0.05* | 0.982 (0.922 - 1.045) | 0.7 |
Lateral lymph node metastasis | 0.863 (0.816 - 0.913) | 0.0001* | 0.887 (0.817 - 0.963) | 0.04* |
Total nodes resected | 0.997 (0.987 - 1.008) | 0.65 |
|
|
Lymph node ratio | 0.978 (0.970 - 0.986) | 0.0003* | 0.988 (0.977 - 0.999) | 0.08 |
Ps-Tg | 0.838 (0.803 - 0.876) | <0.0001* | 0.857 (0.820 - 0.896) | <0.0001* |
TPOAb | 1.004 (1.000 - 1.009) | 0.34 |
|
|
TgAb | 1.005 (0.999 - 1.010) | 0.41 |
|
|